digipharm®
Home •  Site Map  •  Research  •  Reports  •  International Experts  •  Music Preparations  •  Fundamentals  •  News  •  Questions  •  Shop
digipharm®
peter huebner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

SCIENTIFIC RESEARCH

Research Fields in Detail

Cardiovascular System

Hemodynamic

Cerebral Arteries

Blood Pressure

Heart Frequency

Heart Rate

Neurodermatitis

Neurodermatitis

High Blood Pressure

OPH Syndrome

OPH Syndrome

Fetal Heart Activity

 

 






Improved Cardiac Activity of the Foetus in Pregnant Women at Risk with a Mild Form of the OPH-Syndrome







With the help of a cardiotocogram the heart activity of the fetus was investigated. The women were in the third trimester of preg­nancy and suffered from a mild form of the OPH-syndrome (gestosis – nephropathy – with swellings at the feet, later at the whole body, hypertension, too much protein in urine) and the status of the fetal heart activity was problematic.


Medical Resonance Therapy Music® Group

For 7-10 days 13 women with an average age of 26 years (±0,6) listened to the Medical Reso­nance Therapy Music® in the morning and after lunch and had no other therapy dur­ing these days.

The cardiotocogram documented in 86% of the investigations a normalization of the state of the fetus. This was also subjectively con­firmed by the pregnants who felt better and better. Already after the 6th sitting ac­cel­era­tions and variability of fetal heart beat had im­proved documenting an improved function of the fetal-placental system. Treatment could be ended after 12 days (±1) in this group.
Control Group


14 women in this group received sedative and hypotensive drugs as well as a phy­to­thera­peu­tic treatment. The state of the fetus also normalized after 6 treatments with drugs, but it took on average 3-4 days longer before the normal state was reached. The mean duration of treatment in this group was 14 days (±2).












 

Investigators:

Prof. Dr. med. G. Gerassimowitsch
Prof. Dr. med. Walentina Sidorenko
Dr. med. Swetlana Scheleg




With kind permission of AAR EDITION INTERNATIONAL
© 1998-  DIGIPHARM >